VRAX Virax Biolabs Group Limited
Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the U…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
 Virax Biolabs enters immune profiling product supply deal with Fosun The collaboration initially focuses on tuberculosis research in Thailand, where Fosun has identified customer interest. | ||
 Virax Biolabs enters immune profiling product supply deal with Fosun The collaboration initially focuses on tuberculosis research in Thailand, where Fosun has identified customer interest. | ||
 Why Did Virax Biolabs Stock Triple In One Session? Virax Biolabs Group Limited (NASDAQ:VRAX) stock is up during Thursday’s premarket session, as the company has signed a multi-country commercial supply agreement with Fosun Diagnostics for its ImmuneSelect product line, which is aimed at immune profiling. The agreement opens access to multiple Southeast Asian markets, potentially driving significant revenue growth for the company as it expands its commercial footprint. Virax Biolabs is developing in vitro diagnostic technologies for viral and imm | ||
 Virax Biolabs Shares Double After Exclusive Fosun Distribution Agreement (VRAX) Virax Biolabs Signs Multi-Country Supply PartnershipVirax Biolabs Group Limited (NASDAQ:VRAX) shares surged 100% on Thursday after the company announced an exclusive commercial supply agreement with Fosun Diagnostics for its ImmuneSelect immune profiling product portfolio. The agreement covers six Southeast Asian markets—Thailand, Vietnam, Indonesia, the Philippines, Singapore and Malaysia—and establishes a framework for immediate product shipments through purchase orders, creating new near-term | ||